DTC Price Disclosure Should Include Cost Sharing Context, Patient Groups Tell CMS
Executive Summary
Some patient groups, payers support CMS proposal to require disclosure of list prices in TV ads but want to expand the requirement to other media and beef up enforcement. Others are skeptical the proposal would lower prices.
You may also be interested in...
DTC Ad Proposal: Biopharma, Advertisers Marshall Legal Arguments In Opposition
Industry comments urge CMS to withdraw proposed rule mandating list price disclosures in TV ads, citing legal conflicts.
US Drug Pricing: CMS Seeks Feedback On DTC Ad Enforcement Mechanism, Disclosure Statement
Centers for Medicare and Medicaid Services asks whether private actions under Lanham Act are sufficient for enforcement, or whether participation in federal health programs should be conditioned on including drug list prices in direct-to-consumer TV commercials; comment deadline on controversial proposed rule is Dec. 17.
Trump Administration's Rx-Price-Disclosure Reg Sets Up Legal Fight With PhRMA
From kinds of ads targeted to agency that's issuing the reg, policy seems designed to withstand a court challenge.